yttrium radioisotopes has been researched along with Minimal Disease, Residual in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amato, A; Carriero, PL; McVie, G; Paganelli, G | 1 |
| Bodet-Milin, C; Chevallier, P; Delaunay, J; Escoffre-Barbe, M; Eugene, T; Goldenberg, DM; Guillaume, T; Kraeber-Bodéré, F; Le Houerou, C; Menard, A; Robillard, N; Wegener, WA | 1 |
| Charles, HW; Deipolyi, AR; Park, J; Patel, P | 1 |
| Abdel-Misih, R; Dignazio, M; Garcia, M; Khatri, J; Neff, R; Petrelli, N; Wilson, P | 1 |
| Chan, M; Ho, R; Ho, S; Johnson, PJ; Lau, WY; Leung, TW; Li, AK | 1 |
5 other study(ies) available for yttrium radioisotopes and Minimal Disease, Residual
| Article | Year |
|---|---|
A Novel Injectable Hydrogel Matrix Loaded With 90Y Microspheres for the Treatment of Solid Tumors.
Topics: Animals; Antineoplastic Agents; Chemoradiotherapy, Adjuvant; Hydrogels; Injections; Kidney Neoplasms; Male; Microspheres; Neoplasm, Residual; Neoplasms, Experimental; Rabbits; Tissue Distribution; Treatment Outcome; Yttrium Radioisotopes | 2022 |
BCR-ABL1 molecular remission after 90Y-epratuzumab tetraxetan radioimmunotherapy in CD22+ Ph+ B-ALL: proof of principle.
Topics: Antibodies, Monoclonal, Humanized; Bone Marrow; Female; Fusion Proteins, bcr-abl; Humans; Immunophenotyping; Middle Aged; Neoplasm, Residual; Phenotype; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Radioimmunotherapy; Remission Induction; Sialic Acid Binding Ig-like Lectin 2; Treatment Outcome; Yttrium Radioisotopes | 2013 |
Arterial Changes Due to Chemoembolization of Hepatocellular Carcinoma Impacting Subsequent Radioembolization.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Collateral Circulation; Computed Tomography Angiography; Cone-Beam Computed Tomography; Doxorubicin; Embolization, Therapeutic; Female; Hepatic Artery; Humans; Liver Circulation; Liver Neoplasms; Neoplasm, Residual; Radiopharmaceuticals; Regional Blood Flow; Retreatment; Treatment Outcome; Yttrium Radioisotopes | 2016 |
The toxicity of liver directed yttrium-90 microspheres in primary and metastatic liver tumors.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Female; Hepatic Artery; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Pancreatic Neoplasms; Retrospective Studies; Survival Rate; Yttrium Radioisotopes | 2008 |
Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres.
Topics: Adult; Aged; Aged, 80 and over; alpha-Fetoproteins; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cause of Death; Dose Fractionation, Radiation; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Survival Analysis; Yttrium Radioisotopes | 1998 |